The effects of post-translational processing on dystroglycan synthesis and trafficking
- PMID: 14644417
- DOI: 10.1016/s0014-5793(03)01230-4
The effects of post-translational processing on dystroglycan synthesis and trafficking
Abstract
Dystroglycan is a component of the dystrophin glycoprotein complex that is cleaved into two polypeptides by an unidentified protease. To determine the role of post-translational processing on dystroglycan synthesis and trafficking we expressed the dystroglycan precursor and mutants thereof in a heterologous system. A point mutant in the processing site, S655A, prevented proteolytic cleavage but had no effect upon the surface localisation of dystroglycan. Mutation of two N-linked glycosylation sites that flank the cleavage site inhibited proteolytic processing of the precursor. Furthermore, chemical inhibition of N- and O-linked glycosylation interfered with the processing of the precursor and reduced the levels of dystroglycan at the cell surface. Dystroglycan processing was also inhibited by the proteasome inhibitor lactacystin. N-linked glycosylation is a prerequisite for efficient proteolytic processing and cleavage and glycosylation are dispensable for cell surface targeting of dystroglycan.
Similar articles
-
Biosynthesis of dystroglycan: processing of a precursor propeptide.FEBS Lett. 2000 Feb 18;468(1):79-83. doi: 10.1016/s0014-5793(00)01195-9. FEBS Lett. 2000. PMID: 10683445
-
Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties.J Biol Chem. 1995 Jun 23;270(25):15425-33. doi: 10.1074/jbc.270.25.15425. J Biol Chem. 1995. PMID: 7797531
-
Molecular recognition by LARGE is essential for expression of functional dystroglycan.Cell. 2004 Jun 25;117(7):953-64. doi: 10.1016/j.cell.2004.06.003. Cell. 2004. PMID: 15210115
-
Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.Glycobiology. 2003 Aug;13(8):55R-66R. doi: 10.1093/glycob/cwg076. Epub 2003 May 7. Glycobiology. 2003. PMID: 12736199 Review.
-
Defective glycosylation in muscular dystrophy.Lancet. 2002 Nov 2;360(9343):1419-21. doi: 10.1016/S0140-6736(02)11397-3. Lancet. 2002. PMID: 12424008 Review.
Cited by
-
Native DGC structure rationalizes muscular dystrophy-causing mutations.Nature. 2025 Jan;637(8048):1261-1271. doi: 10.1038/s41586-024-08324-w. Epub 2024 Dec 11. Nature. 2025. PMID: 39663457
-
A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.Brain Pathol. 2009 Oct;19(4):596-611. doi: 10.1111/j.1750-3639.2008.00198.x. Epub 2008 Aug 7. Brain Pathol. 2009. PMID: 18691338 Free PMC article.
-
High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.J Biol Chem. 2012 Jun 29;287(27):22759-70. doi: 10.1074/jbc.M111.334581. Epub 2012 May 8. J Biol Chem. 2012. PMID: 22570487 Free PMC article.
-
A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.J Virol. 2020 Mar 17;94(7):e01751-19. doi: 10.1128/JVI.01751-19. Print 2020 Mar 17. J Virol. 2020. PMID: 31915280 Free PMC article.
-
A molecular overview of the primary dystroglycanopathies.J Cell Mol Med. 2019 May;23(5):3058-3062. doi: 10.1111/jcmm.14218. Epub 2019 Mar 5. J Cell Mol Med. 2019. PMID: 30838779 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources